Atlas Trials

CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

Clinical trial NCT02693080 · COMPLETED

Trial details

NCT number
NCT02693080
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Lung NeoplasmMetastatic Malignant Neoplasm in the LungNon-Small Cell Lung CarcinomaStage IV Lung Cancer
Start date
2016-01-19
Primary completion
2020-04-29
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.